Article By:
Zacks Investment Research
Friday, February 3, 2017 9:00 PM EDT
Novo Nordisk A/S reported fourth-quarter 2016 earnings of 50 cents per American Depositary Receipt (ADR), missing the Zacks Consensus Estimate of 52 cents by 3.8%. Reported earnings, however, surpassed the year ago figure of 48 cents.
